Seer, Inc.
NASDAQ:SEER · NASDAQ Global Select
+$0.01 today
Vol 0.08M · Avg 0.32M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-11.68%
Period High
$2.37
Period Low
$1.66
Latest
$1.74
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Kymera Therapeutics, Inc.
NASDAQ:KYMR
$7.40B
Pharvaris N.V.
NASDAQ:PHVS
$2.29B
Mineralys Therapeutics, Inc.
NASDAQ:MLYS
$1.65B
Nurix Therapeutics, Inc.
NASDAQ:NRIX
$1.48B
Monte Rosa Therapeutics, Inc.
NASDAQ:GLUE
$1.18B
Cullinan Therapeutics, Inc.
NASDAQ:CGEM
$943.77M
ORIC Pharmaceuticals, Inc.
NASDAQ:ORIC
$894.39M
Sana Biotechnology, Inc.
NASDAQ:SANA
$869.66M
C4 Therapeutics, Inc.
NASDAQ:CCCC
$335.86M
Lyell Immunopharma, Inc.
NASDAQ:LYEL
$294.24M
Foghorn Therapeutics Inc.
NASDAQ:FHTX
$242.78M
Shattuck Labs, Inc.
NASDAQ:STTK
$231.97M
Quantum-Si incorporated
NASDAQ:QSI
$196.42M
Nkarta, Inc.
NASDAQ:NKTX
$194.67M
Molecular Partners AG
NASDAQ:MOLN
$147.61M
AN2 Therapeutics, Inc.
NASDAQ:ANTX
$136.19M
PepGen Inc.
NASDAQ:PEPG
$124.28M
MediciNova, Inc.
NASDAQ:MNOV
$65.22M
Generation Bio Co.
GBIO
$35.98M
Anebulo Pharmaceuticals, Inc.
ANEB
$17.23M
HCW Biologics Inc.
HCWB
$2.21M
What is the latest SEER filing?
The latest filing shown is DFAN14A dated Jun 15, 2026.
How many recent filings does SEER have?
Intrinsic Alpha currently shows 20 recent filings for SEER.
Explore More
Continue the stock analysis
Jump to another research area for this company.